Senior Vice President
Fletcher Spaght, Inc.
Guy is a senior member of FSI’s Healthcare Practice and has over 30 years of experience in health care, life sciences, and biotechnology. He has particular interest in bioprocessing/biomanufacturing, digital health/personalized medicine, and cost reducing strategies ranging from value-based reimbursement to biosimilars.
Previously, Dr. Fish was Vice President of Business Development and International at Collagenesis, a tissue-engineering firm. He has also worked as a securities analyst in the medical devices sector for Sanford Bernstein, as a healthcare consultant at The Boston Consulting Group, and as a solo practice physician.
Dr. Fish is a Trustee Advisor of Beth Israel Deaconess Medical Center in Boston, where he previously chaired the Patient Care Committee, and holds membership on the Patient Care Assessment and Quality Committee, and Medical Education Committee. He has served as Chairman of the Licensing Board for Dubai Health Care, as well as the Licensing Committee for the Board of Registration in Medicine for the Commonwealth of Massachusetts. Dr. Fish is currently a member of the Board of Directors of Altarum Institute, Phase Biosciences, and is a Board observer of Proteus Digital Health.
Dr. Fish holds an MBA from the Yale School of Management, an MD from the Yale School of Medicine, and an AB in biochemistry from Harvard College. He is Board Certified in Internal Medicine.